https://www.selleckchem.com/pr....oducts/carfilzomib-p
0% to 18.7% after 28.4 weeks, and the effective and cure rates were 66.7% and 16.7%, respectively. The improvement rate per month of combination therapy (12.6%) was higher than that with monotherapy (2.1%) (p = 0.002). There were no serious side-effects. This sequential combination therapy with efinaconazole was effective in poor terbinafine responders, making it a promising regimen for improving the cure rate of tinea unguium.Macrophages are an integral part of all organs in the body, where they contribute to immune surveill
Like
Comment
Share
